16-86532114-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001159377.2(MTHFSD):c.1049C>T(p.Pro350Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000957 in 1,546,682 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001159377.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MTHFSD | NM_001159377.2 | c.1049C>T | p.Pro350Leu | missense_variant | 8/8 | ENST00000360900.11 | NP_001152849.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MTHFSD | ENST00000360900.11 | c.1049C>T | p.Pro350Leu | missense_variant | 8/8 | 1 | NM_001159377.2 | ENSP00000354152.6 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 151738Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000496 AC: 9AN: 181474Hom.: 0 AF XY: 0.0000402 AC XY: 4AN XY: 99626
GnomAD4 exome AF: 0.0000925 AC: 129AN: 1394824Hom.: 0 Cov.: 29 AF XY: 0.0000903 AC XY: 62AN XY: 686250
GnomAD4 genome AF: 0.000125 AC: 19AN: 151858Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74198
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The c.1049C>T (p.P350L) alteration is located in exon 8 (coding exon 8) of the MTHFSD gene. This alteration results from a C to T substitution at nucleotide position 1049, causing the proline (P) at amino acid position 350 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at